Uncategorized

Ribbon Biolabs, the DNA synthesis company, announced the appointment of Jodi Barrientos as Chief Business Officer.

CellFE Inc. announced the commercial availability of its Infinity Mtx™ cellular engineering platform, which uses rapid cell compression and re-expansion to actively transport a target payload into the cell.

Innate Pharma SA reported its consolidated financial results for the quarter ending March 31, 2023.

Boehringer Ingelheim and Zealand Pharma A/S announced that patients treated with BI 456906 achieved up to 14.9% weight loss after 46 weeks, using the planned maintenance dose.

MannKind Corporation reported financial results for the quarter ended March 31, 2023.

CTI BioPharma announced that it has entered into a definitive agreement under which Swedish Orphan Biovitrum AB, a global healthcare leader in hematology, immunology and specialty care, will acquire CTI for $9.10 per share of common stock in an all-cash transaction, representing an implied equity value of approximately $1.7 billion.

Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announced that the first patient has been dosed in Delivir, a Phase I clinical trial evaluating TG6050.

Lucence unveiled LucenceINSIGHT™, its pioneering multi-cancer early detection blood test, at their US headquarters.

UNION therapeutics A/S announced that Dr. Kim D. Kjøller, CEO of UNION therapeutics will present at the seminar on hidradenitis suppurativa at the 4th Annual Dermatology Drug Development Summit Europe on May 22-24, 2023, in Berlin, Germany.

IRLAB Therapeutics Gothenburg, Sweden, May 10, 2023 – IRLAB Therapeutics AB, a company discovering and developing novel treatments for Parkinson’s disease, announced that the company’s interim report for the period January-March 2023, has been published.